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Fetal bovine serum: geographic origin 
and regulatory relevance of viral contamination
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Abstract 
The article aims to clarify an existing misunderstanding by the users of fetal bovine serum (FBS), who assume that cer-
tain countries, like Australia and New Zealand, have fewer cattle disease viruses and pose less risk for the presence of 
viruses, than do the other FBS producing countries. The article reviews the 2013 information from the World Organi-
zation for Animal Health (OIE), regarding the presence and absence of the 14 viruses of concern for FBS in the cattle 
populations of the 30 major FBS producing countries of the world. United States Department of Agriculture (USDA) 
and European Union (EU) regulations have identified 8 adventitious viruses and 6 additional viruses of importation 
concern that need to be tested for or eliminated in FBS, viruses that can cross the placental barrier from the donor 
cow to the fetus. A comparison is made regarding the number of viruses of concern reported presently in each of 
the FBS producing countries. The results of the comparison reveal that four Scandinavian countries report the fewest 
number of viruses of concern for FBS (six in total), while Australia and the USA are among the countries reporting the 
highest numbers of viruses of concern for FBS (ten in total). FBS from Australia and the USA has thus no advantage 
over the other FBS producing countries, regarding the number of viruses needed to be tested for and eliminated.
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Background
Within the fetal bovine serum (FBS) industry and among 
end users of FBS, there are misconceptions regarding 
the respective geographical origin when sourcing FBS, 
as suggested by Siegel and Foster in a recent Bioprocess-
ing Journal article (Siegel and Foster 2013). One of the 
main preconceptions is that the ‘best’ FBS comes from 
New Zealand and Australia because of their favored ani-
mal health status, and that lesser quality FBS comes from 
other origins with less favored animal health statuses.
Bovine Spongiform Encephalopathy (BSE) used to be 
a disease factor which favored those countries that had 
never reported an outbreak, like New Zealand and Aus-
tralia, as reported by Davis and Drake in another recent 
Bioprocessing Journal (Davis and Drake Hirschi 2014). 
This lead to the promotion of FBS from these two coun-
tries as “safer” than from other origins, regarding BSE 
and other cattle diseases, because Oceania is “isolated” 
from the rest of the world. However, as knowledge of BSE 
advanced, scientists and government regulators from the 
World Organization for Animal Health (OIE), the Euro-
pean Union (EU) and the United States Department of 
Agriculture (USDA) determined that BSE is not trans-
mitted in bovine blood or blood products, when appro-
priate slaughter practices are adhered to.
The purpose of this paper is to compare and discuss the 
animal health statuses of the 30 major producing coun-
tries of FBS, relating to the viruses of concern for FBS. 
We will compare the latest (2013) animal health status of 
these countries using information from the OIE, as well 
as USDA and EU sources, and show which diseases of 
concern for FBS are present and which are absent.
FBS is the most commonly used supplement in ani-
mal cell culture media. Cell cultures have many clinical 
applications in medicine, such as the production of vac-
cines, diagnostic tests, and cell therapy. FBS used in cell 
cultures contains more growth factors than other animal 
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serum media and has the advantage of very low levels of 
antibodies. On the other hand, it has the disadvantage of 
high costs and the need for testing and the elimination of 
adventitious viruses, as do other media of animal origin. 
Serum-free media have been developed to avoid the use 
of animals for cell culture media, and have met with great 
success, especially in the production of some proteins for 
medical uses (Cruz et al. 1998). However, pharmaceutical 
companies, diagnostic labs and researchers still depend 
heavily on FBS for most of their cell culture needs. 
Researchers have not been able yet to replicate all the 
growth factors present in FBS or to produce serum-free 
media on a large enough scale, allowing for a complete 
replacement of FBS. The pharmaceutical and biologics 
community will most likely continue depending on FBS 
for many more years.
Review
Origins, diseases and rule setting
Not all countries qualify for exporting FBS because 
of certain diseases in their cattle populations, and the 
related import restrictions imposed by importing coun-
tries. These restrictions are imposed because of the ani-
mal diseases present in the exporting country and the 
perceived or real risk of viruses being present in imported 
FBS. The purpose of import requirements is to guarantee 
the absence of viruses of concern, by either prohibiting 
importation, or by other measures such as safety testing, 
and gamma irradiation. Once having passed importation 
requirements, safety testing and/or sterilization treat-
ment, the imported FBS is considered to be free of all 
viruses of importation concern, and comparable to FBS 
from any approved origin.
Given the fact that the two largest global markets for 
animal-derived products are the United States of Amer-
ica (USA) and Europe, the import requirements from the 
USDA and the European Commission (EC), to a great 
extent, have become the veterinary control standards for 
the FBS industry. Since the 1980’s, the principal source 
countries for FBS are from North, Central and South 
America, and Oceania. Europe is being added to this 
list, now that Bovine Spongiform Encephalopathy (BSE) 
is no longer considered to be transmitted by blood and 
blood products. The 30 countries where FBS is collected 
all have in common their freedom from the major con-
tagious viral diseases of cattle, such as Foot and Mouth 
Disease (FMD), Rinderpest, Peste des petits ruminants, 
and Rift Valley Fever.
The cattle diseases of concern for FBS are those which 
cross the placental barrier of the cow and infect the calf 
fetus, thus contaminating FBS and making it unsuit-
able for use in cell cultures. From a geographic perspec-
tive, some of these viruses (adventitious viruses) are 
considered to have a worldwide distribution, and others 
(viruses of importation concern) are limited to certain 
regions of the world. Table 1 compares the disease status 
of the 30 FBS exporting countries for eight adventitious 
viruses and for six viruses of importation concern. The 
sources for this information are the OIE, the USDA, and 
the EU.
Adventitious viruses
The USDA (USDA 9 CFR 113.46-53) and EU (EMEA-
CPMP-BWP-1793-02) regulations require that all FBS, 
regardless of country of origin, be tested and/or treated 
(by heat or gamma irradiation) to assure its freedom of 
the following eight adventitious viruses: bovine viral 
diarrhea (BVD), infectious bovine rhinotracheitis (IBR), 
parainfluenza 3 (PI3), rabies, reovirus 3 (REO3), bovine 
adenovirus (BAV), bovine parvovirus (BPV), and bovine 
respiratory syncytial virus (BRSV). Because these eight 
viruses affect cattle in all continents of the world, they 
may unintentionally be present in FBS from any origin. 
The cell culture testing procedures required by USDA 
and EU serve not only to detect these eight viruses, but 
also to detect hemagglutination/hemadsorption and 
cytopathic effects caused by other viruses, which can 
contaminate FBS.
Even though these eight adventitious viruses are consid-
ered to be present in all cattle producing areas, the OIE 
(http://www.oie.int/animal-health-in-the-world/official-
disease-status/fmd/) reports the following exceptions:
Bovine Viral Diarrhea (BVD) is reported absent in 
three Scandinavian countries (Finland, Norway and 
Sweden). Several other European countries have also 
achieved significant success toward eradicating BVD 
(Switzerland, Austria, Scotland, Ireland, Sweden, Den-
mark and Germany).
Infectious Bovine Rhinotracheitis (IBR) is also reported 
absent in 4 Scandinavian countries, the same three coun-
tries mentioned above, plus Denmark.
Rabies has never been reported in New Zealand, and is 
reported absent in Australia, as well as the four Scandina-
vian countries mentioned above, plus Belgium, Germany 
and Ireland.
Viruses of importation concern
The viruses of concern for FBS which do not have a 
worldwide distribution are also of concern when import-
ing FBS. Regulations from USDA (Veterinary Services 
Notice 1998) and EU (Regulation EC No 294-2013) 
identify six viruses of importation concern for the FBS 
producing areas of the world: Foot and Mouth Disease 
(FMD), Vesicular Stomatitis, Blue Tongue, Akabane, 
Aino (Veterinary Services Notice 1992), and Schmallen-
berg (USDA Schmallenberg Restrictions). FMD is the 
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Finland + + + + + 2010 1994 2007 5
Norway + + + + + 2005 1992 2011 5
Sweden + + + + + 2011 1995 1886 5
Denmark + + + + + + 2005 2002 6
New Zealand + + + + + + + – 7
Belgium + + + + + + + 2008 7
Chile + + + + + + + + 8
Germany + + + + + + + 2005 7
Ireland + + + + + + + 1903 7
Uruguay + + + + + + + + 8
Argentina + + + + + + + + 8
Canada + + + + + + + + 8
Colombia + + + + + + + + 8
Dominican 
Republic
+ + + + + + + + 8
El Salvador + + + + + + + + 8
Guatemala + + + + + + + + 8
Honduras + + + + + + + + 8
Holland + + + + + + + + 8
Mexico + + + + + + + + 8
Nicaragua + + + + + + + + 8
Panama + + + + + 2007 + + 7
Paraguay + + + + + + + + 8
Peru + + + + + + + + 8
Poland + + + + + + + + 8
Australia + + + + + + + 1867 7
Brazil + + + + + + + + 8
Costa Rica + + + + + + + + 8
France + + + + + + + + 8
Spain + + + + + + + + 8
United States + + + + + + + + 8
FBS exporting 
countries
Viruses of importation concern Total 
viruses of 














Finland 1959 – – – – + 1 6
Norway 1952 – 2010 – – + 1 6
Sweden 1966 – 2009 – – + 1 6
Denmark 1983 – 2009 – – + 1 7
New Zealand – – – – – – 0 7
Belgium 1976 – 2008 – – + 1 8
Chile 1987 – – – – – 0 8
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only one of these diseases which is not an insect vectored 
disease.
Non‑insect vectored disease
Foot and Mouth Disease (FMD) All 30 countries are 
officially recognized by the OIE as free of FMD (http://
www.oie.int/animal-health-in-the-world/official-disease-
status/fmd/). The South American countries listed in 
Table  1 are free of FMD with vaccination (except Chile 
which is free without vaccination), and the remaining 
countries on the list are free of FMD without vaccination.
Currently, the major difference between US and EU 
importation rules for FBS is over the definition of FMD 
free status. The EU accepts FBS from countries free of 
FMD, both with and without vaccination, whereas the 
USA only accepts FBS from countries free of FMD with-
out vaccination. As a result, today’s commercialization of 
FBS from South American origins (with the exception of 
Chile) is limited to Europe and Asia.
Even with the conservative approach taken by USDA, 
it should be noted that there are no literature reports of 
the FMD virus or FMD antibodies ever being found in 
bovine fetuses or FBS.
Insect vectored diseases
Vesicular stomatitis virus (VSV) is of concern to the 
European countries because the virus only exists in the 
Americas and because its clinical presentation is identi-
cal to FMD, even though the two viruses are from differ-
ent families (VSV from the Rhabdoviridae and FMD from 
Picornaviridae). VSV is spread by insects and is endemic 
in the tropical and semitropical areas of the Americas. 
Every few years, VS spreads into the adjacent temperate 
areas of North and South America.
(Year) indicates year disease last reported; (+) disease is present; (−) disease has never been reported.
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Germany 1988 – 2009 – – + 1 8
Ireland 2001 – – – – + 1 8
Uruguay 2001 – – – – – 0 8
Argentina 2006 1986 + – – – 1 9
Canada 1952 1949 + – – – 1 9
Colombia 2009 + 2007 – – – 1 9
Dominican 
Republic
– – + – – – 1 9
El Salvador – + 1997 – – – 1 9
Guatemala – + 1998 – – – 1 9
Honduras – + 2004 – – – 1 9
Holland 2001 – 2009 – – + 1 9
Mexico 1954 + 2010 – – – 1 9
Nicaragua – + 2009 – – – 1 9
Panama – + No Info – – – 2 9
Paraguay 2012 – Unknown – – – 1 9
Peru 2004 + 2004 – – – 1 9
Poland 1971 – – – – + 1 9
Australia 1871 – + + + – 3 10
Brazil 2006 + + – – – 2 10
Costa Rica – + + – – – 2 10
France 2001 – + – – + 2 10
Spain 1986 – + – – + 2 10
USA 1929 + + – – – 2 10
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Blue tongue virus (BTV) occurs in all tropical and semi-
tropical climates of the world where biting midge vectors 
exist, and there are 24 distinct serotypes in different areas 
of the world (http://www.oie.int/fileadmin/Home/eng/
Animal_Health_in_the_World/docs/pdf/Disease_cards/
BLUETONGUE.pdf). Importation requirements are in 
place for this virus, in order to prevent the introduction 
of new serotypes from other parts of the world. Every few 
years, the virus reappears in areas where biting midges 
exist. USDA requires that serum from all countries, 
except Canada and New Zealand, be tested for BTV. 
Canada has the same serotypes of BTV as the USA, and 
New Zealand has never reported BTV.
Akabane, aino and schmallenberg viruses (Simbu 
Serogroup viruses) are transmitted by insects and cause 
deformities and death in bovine fetuses. USDA requires 
Australian serum be tested for Akabane. The same test 
detects the Aino Virus, which is also present in Australia. 
USDA also has import restrictions for European animal 
byproducts relating to Schmallenberg.
Comparing origins of FBS
First and foremost, it should be noted that all 30 coun-
tries listed on Table  1 are officially recognized by the 
OIE as being free of FMD, a remarkable accomplishment 
requiring excellent disease detection and surveillance 
programs.
Regarding the other five viruses of importation con-
cern: all 30 countries are free of Akabane and Aino 
viruses, except Australia; only the European countries are 
affected by the Schmallenberg virus; only the Americas 
are affected by VSV; and all three continents represented 
are occasionally affected by different strains of BTV.
Next, regarding the eight adventitious viruses: all 30 
countries are considered to be infected with PI3, REO3, 
BAV, BPV and BRSV; six European countries, as well 
as Oceania are free of Rabies; and several Scandinavian 
countries report the absence of BVD and IBR.
The countries reporting the fewest (6–7) viruses of 
concern for FBS are Finland, Norway, Sweden, Denmark 
and New Zealand.
The countries reporting the most (10) viruses of con-
cern for FBS are Australia, Brazil, Costa Rica, France, 
Spain, and the USA.
Conclusions
Regardless of geographical location, FBS from all 30 
countries needs to be tested and treated for the presence 
of multiple viruses. No one continent or country which 
produces FBS seems to have a real advantage over the 
others, since all countries have viruses of regulatory con-
cern needing to be tested for and eliminated in FBS.
The comparisons made in this article, concerning 
the animal health statuses of the major FBS producing 
countries, show why a correlation between geographi-
cal origin and the “quality” of FBS based on the country’s 
animal health status is not reasonable.
Just because the prices of FBS from certain origins 
might be higher, does not mean that those origins are 
“safer”, in terms of the number of viruses needing to be 
tested for and eliminated.
Once having passed importation requirements, safety 
testing and sterilization treatment, FBS is considered to 
be free of all viruses of importation concern, and compa-
rable to FBS from any other approved origin.
Finally, safe FBS can come from any of the USDA and 
EU approved origins.
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